PIM1 kinase is destabilized by ribosomal stress causing inhibition of cell cycle progression

Oncogene

Volumn 29, Issue 40, 2010, Pages 5490-5499

  Iadevaia, V ^a   Caldarola, S ^a   Biondini, L ^a   Gismondi, A ^a   Karlsson, S ^b   Dianzani, I ^c   Loreni, F ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

cell cycle arrest; erythroleukemia cells; p27Kip1; PIM1; ribosome synthesis; RPS19

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; PROTEIN KINASE PIM 1; PROTEIN P53; RIBOSOME PROTEIN; PIM1 PROTEIN, HUMAN; RIBOSOMAL PROTEIN S19;

ARTICLE; CELL CYCLE ARREST; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ERYTHROID CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RIBOSOME; RNA INTERFERENCE; CELL CYCLE; CELL SEPARATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SEPARATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; PROTO-ONCOGENE PROTEINS C-PIM-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBOSOMAL PROTEINS; RIBOSOMES; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77957757746     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.279     Document Type: Article

References (34)

1. Anderson SJ, Lauritsen JP, Hartman MG, Foushee AM, Lefebvre JM, Shinton SA et al. (2007). Ablation of ribosomal protein L22 selectively impairs alphabeta T cell development by activation of a p53-dependent checkpoint. Immunity 26: 759-772.
2. Bachmann M, Moroy T. (2005). The serine/threonine kinase Pim-1. Int J Biochem Cell Biol 37: 726-730.
3. Badhai J, Frojmark AS, Razzaghian HR, Davey E, Schuster J, Dahl N. (2009). Posttranscriptional down-regulation of small ribosomal subunit proteins correlates with reduction of 18S rRNA in RPS19 deficiency. FEBS Lett 583: 2049-2053.
4. Caldarola S, De Stefano MC, Amaldi F, Loreni F. (2009). Synthesis and function of ribosomal proteins\fading models and new perspectives. FEBS J 276: 3199-3210.
5. Chiocchetti A, Gibello L, Carando A, Aspesi A, Secco P, Garelli E et al. (2005). Interactions between RPS19, mutated in Diamond-Blackfan anemia, and the PIM-1 oncoprotein. Haematologica 90: 1453-1462.
6. Danilova N, Sakamoto KM, Lin S. (2008). Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family. Blood 112: 5228-5237.
7. Fatica A, Tollervey D. (2002). Making ribosomes. Curr Opin Cell Biol 14: 313-318.
8. Fumagalli S, Di Cara A, Neb-Gulati A, Natt F, Schwemberger S, Hall J et al. (2009). Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction. Nat Cell Biol 11: 501-508.
9. Hammerman PS, Fox CJ, Birnbaum MJ, Thompson CB. (2005). Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival. Blood 105: 4477-4483.
10. Idol RA, Robledo S, Du HY, Crimmins DL, Wilson DB, Ladenson JH et al. (2007). Cells depleted for RPS19, a protein associated with Diamond-Blackfan anemia, show defects in 18S ribosomal RNA synthesis and small ribosomal subunit production. Blood Cells Mol Dis 39: 35-43.
11. Laird PW, van der Lugt NM, Clarke A, Domen J, Linders K, McWhir J et al. (1993). In vivo analysis of Pim-1 deficiency. Nucleic Acids Res 21: 4750-4755.
12. Larrea MD, Wander SA, Slingerland JM. (2009). p27 as Jekyll and Hyde: regulation of cell cycle and cell motility. Cell Cycle 8: 3455-3461.
13. Liu JM, Ellis SR. (2006). Ribosomes and marrow failure: coincidental association or molecular paradigm? Blood 107: 4583-4588.
14. Losman JA, Chen XP, Vuong BQ, Fay S, Rothman PB. (2003). Protein phosphatase 2A regulates the stability of Pim protein kinases. J Biol Chem 278: 4800-4805.
15. Mayer C, Grummt I. (2005). Cellular stress and nucleolar function. Cell Cycle 4: 1036-1038.
16. McGowan KA, Li JZ, Park CY, Beaudry V, Tabor HK, Sabnis AJ et al. (2008). Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects. Nat Genet 40: 963-970.
17. Miyake K, Flygare J, Kiefer T, Utsugisawa T, Richter J, Ma Z et al. (2005). Development of cellular models for ribosomal protein S19 (RPS19)-deficient Diamond-Blackfan anemia using inducible expression of siRNA against RPS19. Mol Ther 11: 627-637.
18. Morishita D, Katayama R, Sekimizu K, Tsuruo T, Fujita N. (2008). Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscrip-tional levels. Cancer Res 68: 5076-5085.
19. Orru S, Aspesi A, Armiraglio M, Caterino M, Loreni F, Ruoppolo M et al. (2007). Analysis of the ribosomal protein S19 interactome. Mol Cell Proteom 6: 382-393.
20. Panic L, Montagne J, Cokaric M, Volarevic S. (2007). S6-haploinsuf- ficiency activates the p53 tumor suppressor. Cell Cycle 6: 20-24.
21. Pestov DG, Strezoska Z, Lau LF. (2001). Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition. Mol Cell Biol 21: 4246-4255.
22. Rubbi CP, Milner J. (2003). Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J 22: 6068-6077.
23. Ruggero D, Pandolfi PP. (2003). Does the ribosome translate cancer? Nat Rev Cancer 3: 179-192.
24. Selten G, Cuypers HT, Berns A. (1985). Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas. EMBO J 4: 1793-1798.
25. Shah N, Pang B, Yeoh KG, Thorn S, Chen CS, Lilly MB et al. (2008). Potential roles for the PIM1 kinase in human cancer\a molecular and therapeutic appraisal. Eur J Cancer 44: 2144-2151.
26. Shay KP, Wang Z, Xing PX, McKenzie IF, Magnuson NS. (2005). Pim-1 kinase stability is regulated by heat shock proteins and the ubiquitin-proteasome pathway. Mol Cancer Res 3: 170-181.
27. Soeiro I, Mohamedali A, Romanska HM, Lea NC, Child ES, Glassford J et al. (2006). p27Kip1 and p130 cooperate to regulate hematopoietic cell proliferation in vivo. Mol Cell Biol 26: 6170-6184.
28. Steinman RA. (2002). Cell cycle regulators and hematopoiesis. Oncogene 21: 3403-3413.
29. Sulic S, Panic L, Barkic M, Mercep M, Uzelac M, Volarevic S. (2005). Inactivation of S6 ribosomal protein gene in T lymphocytes activates a p53-dependent checkpoint response. Genes Dev 19: 3070-3082.
30. Urashima M, Teoh G, Chauhan D, Ogata A, Shirahama S, Kaihara C et al. (1998). MDM2 protein overexpression inhibits apoptosis of TF-1 granulocyte-macrophage colony-stimulating factor-dependent acute myeloblastic leukemia cells. Blood 92: 959-967.
31. van Lohuizen M, Verbeek S, Krimpenfort P, Domen J, Saris C, Radaszkiewicz T et al. (1989). Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell 56: 673-682.
32. Volarevic S, Stewart MJ, Ledermann B, Zilberman F, Terracciano L, Montini E et al. (2000). Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6. Science 288: 2045-2047.
33. Wang Z, Bhattacharya N, Weaver M, Petersen K, Meyer M, Gapter L et al. (2001). Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis. J Vet Sci 2: 167-179.
34. Zippo A, De Robertis A, Serafini R, Oliviero S. (2007). PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation. Nat Cell Biol 9: 932-944.